Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
MannKind Corporation is a biopharmaceutical company specializing in developing and commercializing innovative inhalation-based therapies for endocrine and orphan lung diseases. Its core products include Afrezza, an inhaled insulin, and V-Go, a wearable insulin delivery device. The company leverages proprietary Technosphere dry-powder formulations and inhaler technologies to deliver rapid, convenient treatments primarily in the U.S. and select international markets.
This description was generated via AI from an annual report. Updated about 1 year ago.